Related references
Note: Only part of the references are listed.An in vitro toolbox to accelerate anti-malarial drug discovery and development
Susan A. Charman et al.
MALARIA JOURNAL (2020)
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria
Sreekanth Kokkonda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
K13, the Cytostome, and Artemisinin Resistance
Stanley C. Xie et al.
TRENDS IN PARASITOLOGY (2020)
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
Manu Vanaerschot et al.
CELL CHEMICAL BIOLOGY (2020)
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules
Katarina Roos et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials
Trent D. Ashton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Nicholas J. White
MALARIA JOURNAL (2019)
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019
Julia C. Haston et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model
Rebecca E. K. Mandt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265
John White et al.
ACS INFECTIOUS DISEASES (2019)
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation
Sean C. Murphy et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Malaria Elimination: Time to Target All Species
Andrew A. Lover et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Efficient sampling of puckering states of monosaccharides through replica exchange with solute tempering and bond softening
Lingle Wang et al.
JOURNAL OF CHEMICAL PHYSICS (2018)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas et al.
LANCET INFECTIOUS DISEASES (2018)
Accurate Calculation of Relative Binding Free Energies between Ligands with Different Net Charges
Wei Chen et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
Yevgeniya Antonova-Koch et al.
SCIENCE (2018)
Assessing drug efficacy against Plasmodium falciparum liver stages in vivo
Erika L. Flannery et al.
JCI INSIGHT (2018)
Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach
Hiroshi Nara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs
Li Di et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection
Mihly Sulyok et al.
LANCET INFECTIOUS DISEASES (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Malaria
Margaret A. Phillips et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Changing Antimalarial Drug Sensitivities in Uganda
Stephanie A. Rasmussen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Advancing Drug Discovery through Enhanced Free Energy Calculations
Robert Abel et al.
ACCOUNTS OF CHEMICAL RESEARCH (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
WScore: A Flexible and Accurate Treatment of Explicit Water Molecules in Ligand-Receptor Docking
Robert B. Murphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity
Sreekanth Kokkonda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Artemisinin Action and Resistance in Plasmodium falciparum
Leann Tilley et al.
TRENDS IN PARASITOLOGY (2016)
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
Margaret A. Phillips et al.
ACS INFECTIOUS DISEASES (2016)
Accurate Binding Free Energy Predictions in Fragment Optimization
Thomas B. Steinbrecher et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
Lingle Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Atovaquone Tolerance in Plasmodium falciparum Parasites Selected for High-Level Resistance to a Dihydroorotate Dehydrogenase Inhibitor
Jennifer L. Guler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth
Leila S. Ross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors
Xiaoyi Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery
Maria Belen Jimenez-Diaz et al.
PLOS ONE (2013)
Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA Amplifications
Jennifer L. Guler et al.
PLOS PATHOGENS (2013)
Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide
Matthew P. Repasky et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches
Eric H. Ekland et al.
FASEB JOURNAL (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection
Suresh M. Ganesan et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model
Michael L. Booker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes
Maria Belen Jimenez-Diaz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Quantitative Measurement of Plasmodium-Infected Erythrocytes in Murine Models of Malaria by Flow Cytometry Using Bidimensional Assessment of SYTO-16 Fluorescence
Maria Belen Jimenez-Diaz et al.
CYTOMETRY PART A (2009)
Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds
Xiaoyi Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase
Nicholas A. Malmquist et al.
BIOCHEMISTRY (2008)
Role of the active-site solvent in the thermodynamics of factor Xa ligand binding
Robert Abel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Heather J. Painter et al.
NATURE (2007)
Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding
Tom Young et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor
DE Hurt et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening
M Smilkstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy
TN Bennett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P-vivax is endemic
BM Russell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
RP Austin et al.
DRUG METABOLISM AND DISPOSITION (2002)
Malarial dihydroorotate dehydrogenase
J Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
